Jia JD - Search Results

1

[Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients].

Yao GB, Ren H, Xu DZ, Zhou XQ, Jia JD, Wang YM, Chen CW. Yao GB, et al. Among authors: jia jd. Zhonghua Gan Zang Bing Za Zhi. 2009 Dec;17(12):881-6. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 20038326 Clinical Trial. Chinese.

2

[Clinical study of anti-hepatic fibrosis effect of IFN-gamma in patients with chronic hepatitis B].

Weng HL, Cai WM, Wang BE, Jia JD, Zhou XQ, Shi DM, Zhang DF, Zhao YR, Hao LJ, Wang SY, Wu WF, Xian JZ. Weng HL, et al. Among authors: jia jd. Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):943-7. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12899793 Clinical Trial. Chinese.

3

[The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C].

Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ. Xie Y, et al. Among authors: jia jd. Zhonghua Gan Zang Bing Za Zhi. 2004 Feb;12(2):72-5. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 14980101 Clinical Trial. Chinese.

4

Impact of virus genotype on interferon treatment of patients with chronic hepatitis C: a multicenter controlled study.

Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ. Xie Y, et al. Among authors: jia jd. Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):369-74. Hepatobiliary Pancreat Dis Int. 2004. PMID: 15313671 Clinical Trial.

5

[The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].

Yin SS, Wang BE, Wang TL, Jia JD, Qian LX. Yin SS, et al. Among authors: jia jd. Zhonghua Gan Zang Bing Za Zhi. 2004 Aug;12(8):467-70. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15329205 Clinical Trial. Chinese.

6

[The pegasys using and HCV genotype were the independent predictors of the response to antiviral therapy in chronic hepatitis C].

Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Zhao GZ, Zhang SL, Zhang DZ. Xie Y, et al. Among authors: jia jd. Zhonghua Gan Zang Bing Za Zhi. 2004 Aug;12(8):485-8. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15329210 Clinical Trial. Chinese.

7

[A clinical study of the efficacy and safety of secretory human interferon alpha-2a treatment for chronic hepatitis B].

Wang H, Wang QH, Wang HF, Jia JD, Xie W, Qin XQ. Wang H, et al. Among authors: jia jd. Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):589-92. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15504287 Clinical Trial. Chinese.

8

[Therapeutic strategies for chronic hepatitis B recommended by the American Association for the Study of Liver Diseases].

Wang YC, Jia JD. Wang YC, et al. Among authors: jia jd. Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):623-4. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15504297 Chinese. No abstract available.

9

[The overview of the seminar on chronic hepatitis B].

Jia JD, Zhuang H. Jia JD, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 Nov;12(11):698-9. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15623388 Chinese. No abstract available.

10

Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial.

Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ. Xie Y, et al. Among authors: jia jd. Hepatobiliary Pancreat Dis Int. 2005 May;4(2):213-9. Hepatobiliary Pancreat Dis Int. 2005. PMID: 15908318 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters